Business | The techno-independence movement

China wants to insulate itself against Western sanctions

We assess its progress in six critical technologies

| HONG KONG

A STRIKINGLY HARSH appraisal of China’s ongoing technological battle with America appeared on the website of a prestigious Beijing-based think-tank on January 30th. The paper, published by the Institute of International and Strategic Studies (IISS) at Peking University, found that China is likely to be the bigger loser from the technological and economic decoupling under way between the two world powers. China lacks control over core computing systems, the paper stated, and is far behind America in a number of important areas such as semiconductors, operating systems and aerospace. Within a week of its posting, the document vanished.

The circumstances around its removal are unclear. Communist Party bosses may have decided it signals weakness at a time when Xi Jinping wants to project strength—his country’s, the Communist Party’s and, as he prepares to be anointed president for life later this year, his own. The report’s conclusions are indeed inconvenient for Mr Xi. He has been talking up “self-strengthening” against what his government calls “chokeholds” that the West exerts over access to critical technologies, from seeds to semiconductors. The power of the West to hobble its adversaries with sanctions is about to be tested in Russia, which on February 24th attacked Ukraine (see Briefing). China’s rulers will be watching that military and economic confrontation closely because it may illuminate their own vulnerabilities. China’s 14th five-year plan, a strategic blueprint published in 2021 that covers the years until 2025, makes self-reliance in science and technology a cornerstone of economic policy.

This article appeared in the Business section of the print edition under the headline "The techno-independence movement"

Where will he stop?

From the February 24th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Business

Can biotech startups upstage Eli Lilly and Novo Nordisk?

Smaller drugmakers are enjoying a revival

How to handle populists: a CEO’s survival guide

Western businesses are learning to live with volatile electoral politics around the world


Will war snuff out the Gulf’s global business ambitions?

Companies far and wide are feeling the effects of the conflict